4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- May 26,Expired
- Award
Brief
El Hospital Clínico San Carlos ha prorrogado un contrato con BIOGEN SPAIN S.L. para el suministro de jeringas de NATALIZUMAB (TYSABRI) y cápsulas de DIROXIMEL FUMARATO (VUMERITY) de distribución exclusiva, destinadas al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. El contrato tiene una duración de 6 meses y un valor final de 153.210 €.
Farmasøytisk engroshandel
Result
- BIOGEN SPAIN S.L.Winner
- 1Number of tenders received
- €153,210Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at HOSPITAL CLINICO SAN CARLOS DE MADRID
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Criterio precio
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Contact
Servicio de Contratación Administrativacontratacionadva.hcsc@salud.madrid.org- Result · Dynamic purchasing system · PrequalificationType
- MadridLocation
- 33600000Main codePharmaceutical products